Fundraising FoxShangBay Capital LLC — 2016 Investments
2 investments dated 2016 · listed companies and verified rows first · show all
Berkeley Lights (now Bruker Cellular Analysis) develops the Beacon optofluidic system for single-cell functional analysis, enabling researchers to profile live single cells to discover therapeutic antibodies, interrogate T cells, identify cell therapies, and accelerate cell line development.
BiotechDeep TechHardwareEmeryville, US
Ming Wu(Director)inIgor Khandros(Executive Officer, Director)
BoardMichael Marks(Director)inLip-Bu Tan Tan(Director)Michael Moritz(Director)inWilliam Davidow(Director)
Co-investorsCelesta CapitalCota CapitalKhosla VenturesOpen Field CapitalWalden CatalystAtinum Investment Co. Ltd.+4 more
Immune Onc is a biotechnology company developing medicines to treat patients with hard-to-treat cancers and autoimmune diseases, with expertise in translational medicine and clinical development.
BiotechMedical DevicesPalo Alto, US
Xiaoling Charlene Liao(Executive Officer, Director)Charlene Liao(Founder)in
BoardGuo-Liang Yu(Director)Liqun Luo(Director)
Co-investorsCLI VenturesNorthern Light Venture CapitalStartXVivo CapitalTriWise Capital
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.